Skip to the page

Data / Form D filings / Endolynx Inc.

Endolynx Inc.: Form D filing

Endolynx Inc., a health care company in Jersey City, NJ, filed a Form D with the SEC in 2023. The latest, on March 6, 2023, reports $30,000 sold of a $30,000 offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
77 HUDSON STREET, APT 3303, Jersey City, NJ, 07302
Phone
(646) 504-4465
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1967540

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 6, 2023New notice$30,000$30,0003Nov 4, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Robert JenkinsExecutive Officer, Director
Felek JachimowiczExecutive Officer, Director
David SchanerExecutive Officer, Director

Other health care companies in New Jersey that filed recently

Every Form D from the week of Mar 6, 2023 · All recent filings in New Jersey · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Endolynx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.